Literature DB >> 25580945

Hospital volume and cardiac complications of endomyocardial biopsy: a retrospective cohort study of 9508 adult patients using a nationwide inpatient database in Japan.

Toshiaki Isogai1, Hideo Yasunaga, Hiroki Matsui, Tetsuro Ueda, Hiroyuki Tanaka, Hiromasa Horiguchi, Kiyohide Fushimi.   

Abstract

BACKGROUND: Recent research on complications with endomyocardial biopsy (EMB) has been based on single-center or 2-center studies in high-volume cardiovascular centers. No study has examined the association between hospital volume and the complication rate after EMB. HYPOTHESIS: Hospital volume is inversely associated with cardiac complication rate after EMB.
METHODS: Using the Diagnosis Procedure Combination database in Japan, we identified inpatients aged ≥20 years who underwent EMB under fluoroscopic guidance. We assessed cardiac complications requiring the following urgent procedures on the day of EMB or the day after: pericardiocentesis, surgical repair, and temporary pacing.
RESULTS: Among 9508 eligible patients in 491 hospitals (male, 68%; mean age, 57.0 years), dilated cardiomyopathy was the most frequently diagnosed condition (35.4%). Twenty-four patients (0.25%) required pericardiocentesis on the day of EMB. Three patients (0.03%) underwent surgical repair on the day of EMB or the day after. Sixty-three patients (0.70%) required temporary pacing on the day of EMB. Higher hospital volume was associated with lower rates of pericardiocentesis (low volume, 0.4%; medium volume, 0.2%; high volume, 0.1%; P for the trend test, 0.019) and temporary pacing (low volume, 1.0%; medium volume, 0.7%; high volume, 0.2%; P for the trend test, < 0.001). In a multivariable logistic regression analysis, high hospital volume was significantly associated with a lower rate of the composite outcome of the procedures (reference, low volume; adjusted odds ratio, 0.22; 95% confidence interval, 0.08-0.62, P = 0.004).
CONCLUSIONS: Serious cardiac complications of EMB were rare, but higher hospital volume was associated with lower complication rate.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2015        PMID: 25580945      PMCID: PMC6711019          DOI: 10.1002/clc.22368

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  4 in total

1.  Impact of vascular access site on procedural time of endomyocardial biopsy.

Authors:  Kentaro Mukai; Yusuke Nakano; Tomofumi Mizuno; Toru Niwa; Hirokazu Wakabayashi; Akihiro Suzuki; Atsushi Watanabe; Hirohiko Ando; Kenta Murotani; Katsuhisa Waseda; Tetsuya Amano
Journal:  Heart Vessels       Date:  2018-11-14       Impact factor: 2.037

Review 2.  Imaging tools for assessment of myocardial fibrosis in humans: the need for greater detail.

Authors:  Summer Hassan; Carolyn J Barrett; David J Crossman
Journal:  Biophys Rev       Date:  2020-07-23

3.  Endomyocardial biopsy via the femoral access - still safe and valuable diagnostic tool.

Authors:  Sylwia Sławek; Aleksander Araszkiewicz; Agnieszka Gaczkowska; Justyna Koszarska; Damian Celiński; Marek Grygier; Maciej Lesiak; Stefan Grajek
Journal:  BMC Cardiovasc Disord       Date:  2016-11-15       Impact factor: 2.298

4.  Estimating the Prevalence of Transthyretin Amyloid Cardiomyopathy in a Large In-Hospital Database in Japan.

Authors:  Ian Winburn; Tomonori Ishii; Takuma Sumikawa; Kanae Togo; Hideo Yasunaga
Journal:  Cardiol Ther       Date:  2019-08-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.